New polling data from The Boston Globe reveals that U.S. physicians are prescribing fewer opioids. But how does the trend impact patients – and the
Two American public health epidemics are colliding – creating new headaches for policymakers and more heartache for communities across the country. As the opioid abuse
By Brian Kennedy, Executive Director, Global Alliance for Patient Access A new position paper from the European Crohn’s and Colitis Organisation has garnered attention from physicians and patient advocates
There’s no way to address America’s prescription drug abuse crisis without balanced pain management, explained the National Institutes of Health’s Linda Porter, PhD, at Tuesday’s
Polling results from Tennessee cast new light on a trend that’s sparking national concerns: non-medical switching. As the Tennessee Patient Stability Coalition reports, more than
On the heels of recent research confirming breakthrough drugs’ impact on patients with high cholesterol, the Partnership to Advance Cardiovascular Health has released a quick-draw
Despite being cautioned last year by the Centers for Medicare and Medicaid Services, many states still block patients with hepatitis C from receiving curative treatment.
For patients with extremely high cholesterol, the promise of new PCSK9 inhibitors just keeps growing. Data presented at this month’s American Heart Association meeting confirms